Skip to main content

Understanding the Decision Points of Self-Disclosures and Repayment Obligations

Compliance Key INC - Healthcare Compliance Webinars
                                                          Jay Anstine
Jay Anstine Keynote Speaker at Compliance key Inc. He is the President of Bluebird Healthlaw Partners, LLC. As a healthcare lawyer specializing in regulatory compliance, Mr. Anstine consults to physicians, senior management, and boards of directors on compliance programs and regulatory issues impacting operations. Mr. Anstine's professional background includes working on the provider and the payer side of the market, for large for-profit and non-profit health systems, and small physician-owned entities.
 Webinar Id: LSHCUJA021
 10:00 AM PT | 01:00 PM ET
 12/06/2017
 Duration 60 mins 
Overview
Historically, providers and suppliers enrolled in federal government healthcare programs have reconciled and returned overpayments through various post-payment audits. Additionally, these same entities have voluntarily returned self-identified overpayment through various self-disclosure methods made available to them. When Congress passed the Fraud Enforcement Recovery Act of 2009 ("FERA"), these self-identified disclosures went from strongly encouraged to a mandatory obligation. FERA took the position that to keep the money constituted a "reverse false claim" under the False Claims Act (FCA) (31 U.S.C. 3729-3733). Additionally, new repayment obligations surfaced with the passage of the Patient Protection and Affordable Care Act of 2010.

This presentation will provide a general overview related to the process of disclosing self-identified Medicare overpayments. More specifically, it will walk attendees through the current regulatory framework governing reporting and returning obligations. Additionally, discussion will also include insights on how to conduct an internal review and the decisions involved such as determining when to report and where to disclose. 
Why should you attend this webinar?
If a Medicare participating provider or supplier fails to report and return an overpayment, the entity could face significant fines and penalties under the False Claims Act and the Civil Monetary Penalties Statute (42 U.SC. 1320a-7a). This presentation is designed to help guide you through the process to determine if you have an overpayment to help proactively protect your organization.
Areas Covered in the Session:
  • Overview of reporting and repayment obligations.
  • The Medicare 60-Day Overpayment Rule.
  • The OIG Self Disclosure Protocol.
  • The CMS Self-Referral Disclosure Protocol. 
  • Strategies for conducting an internal review.
  • The reporting process.
  • The repayment process.
  • Questions and answers.
Who can Benefit:
The target audience for this presentation will be new-to-the-profession compliance officers or those in the role at an intermediate level.
Labels:
Location: United States

Comments

Post a Comment

Popular posts from this blog

New 2019 HIPAA Guidance on De-Identifying Protected Health Information

Compliance Key  -   HIPAA Compliance Training Overview This seminar will be addressing how practice/business managers or compliance officers need to get their HIPAA house in order, as HIPAA is now fully enforced and the government is not using kid gloves anymore. It will also address major 2019 changes taking place with the Health and Human Services regarding the enforcement of the HIPAA law as well as detailed discussions on the Phase 2 audit process and current events regarding HIPAA cases (both in courtrooms and from real-life Audits). Our instructor - Mr. Brian Tuttle  has over 20 years of experience in working as Compliance auditor and has been an expert witness on multiple HIPAA cases. He`ll thoroughly explain on HOW and in WHAT scenarios patients can claim for cash remedies. More importantly, Brian will show you how to limit those risks by simply taking proactive steps and utilizing best practices. Why should you attend this seminar? This Sem...
Post a Comment
Read more

Classifying Medical Devices in US and EU

Compliance Key INC  -  Healthcare Compliance Webinars Overview The Food and Drug Administration (FDA) has established classifications for approximately 1,700 different generic types of devices and grouped them into 16 medical specialties referred to as panels. Each of these generic types of devices is assigned to one of three regulatory classes based on the level of control necessary to assure the safety and effectiveness of the device.The determination process, how you apply the classification process to your device, is complex and requires several levels of analysis to make the proper device classification. Proper medical device classification is the fundamental first step in submitting your device for approval anywhere in the world. This webinar will detail the medical device classification process for the United States through the FDA and will overview the very complex process for medical device classification within the EU. Specifically, this webinar will provid...
Post a Comment
Read more

HIPAA Compliance with the New Omnibus Rule: How to Pass an Audit to Avoid Penalties and Criminal Convictions

Compliance Key INC  -  H ipaa webinar                                           Jonathan P. Tomes Jonathan P. Tomes , J.D., is Keynote Speaker at Compliance key Inc. He is a health care attorney practicing in the greater Kansas City.   Webinar Id:   HIPHJPT001  2:30 PM PT | 03:30 PM ET    01/18/2018  Duration: 60 mins  Overview Before the HITECH Act, DHHS could audit covered entities for HIPAA compliance, but did not have to. With that Act, now the must audit those entities and business associates as well. In the first audits, the Phase I audits, DHHS came on site. The subsequent Phase II audits, however, were paper audits in which those audited had to provide documentation of their compliance. As yet, we do not know what form Phase III will take, but the necessary actions to prepar...
Post a Comment
Read more